Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II study

E. ASPINALL ; A. WEIR ; R. SACKS-DAVIS ; T. SPELMAN ; J. GREBELY ; P. HIGGS ; S. J. HUTCHINSON ; M. E. HELLARD | 2014
Dans International Journal of Drug Policy (Vol.25, n°1, January 2014) Article : Périodique

BACKGROUND: People who inject drugs (PWID) are at risk of hepatitis C virus (HCV). It is plausible that PWID who receive a diagnosis of HCV will reduce their injecting risk out of concern for their injecting partners, although evidence for this [...]

Plus d'info

Ajouter à la sélection

High incidence of hepatitis C virus reinfection in a cohort of injecting drug users

C. K. AITKEN ; J. LEWIS ; S. L. TRACY ; T. SPELMAN ; D. S. BOWDEN ; M. BHARADWAJ ; H. DRUMMER ; M. HELLARD | 2008
Périodique

An estimated 170 million people worldwide carry the hepatitis C virus (HCV), and in more developed countries the prevalence and incidence of HCV is particularly high among injecting drug users (IDUs). Spontaneous clearance of HCV infection and r[...]

Plus d'info

Ajouter à la sélection